Abstract
Since the 1990s regulation has been relatively unchanged in the world’s second largest medical technology sector, the European Union. However, recent medical device-related incidents involving breast implants and hip replacements have prompted urgent regulatory and compliance reforms. Against the background of increasing global healthcare costs and an aging population, medical devices including spinal devices are about to undergo one of the industry’s most transformational regulatory changes. What does this mean for current and potential innovators of new medical device technologies and their beneficiaries? What will future reimbursement and regulatory frameworks look like, and what will be their impact on medical device technology investment? Navigating the complex requirements of innovative medical device development such as increasing regulatory burden and a multitude of differing payer uncertainties can often be the hurdle to sustained device innovation for many companies.
NB: this work is not related to the views or opinions of Prism Surgical
References
Arida D, Kabra A, Lowe C, Szafranski AM and Milestone D (2006) The Charité; Lessons in the launch of a new medical device. Bio-medical Marketing
Australian Institute of Health and Welfare (AIHW) (2017) Health expenditure Australia 2015–2016. Health and welfare expenditure series no. 58. Cat. No. JWE68. Based on Australian Institute of Health and Welfare material, Canberra
Bisschop A, van Tulder MW (2016) Market approval processes for new types of spinal devices: challenges and recommendations for improvement. Eur Spine J 25:2993–3003
Center for Devices and Radiological Health (CDRH) (2002) The least burdensome provisions of the FDA modernization act of 1997: concept and principles. Final Guidance for FDA and Industry
Center for Devices and Radiological Health (CDRH) Urogynecologic surgical mesh: update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse, July 2011
Centers for Medicare and Medicaid Services (CMS) (2007) Decision memo for lumbar artificial disc replacement (LADR) (CAG-00292R). https://www.cms.gov/medicare-coverage-database/details/nca-decisionmemo.aspx?NCAId=197&NcaName=Lumbar+Artificial+Disc+Replacement+(LADR)&DocID=CAG-00292R. Date Accessed 01 Aug 2018
De Busscher L, Flockhart A, Baylor-Henry M, Brennan J, Giovannetti G and Kumli F (2016) How the new EU Medical Device Regulation will disrupt and transform the industry. EYGM Limited
Emergo (2017) How long does it take the US FDA to clear medical devices via the 510(k) process? https://www.emergogroup.com/sites/default/files/emergo-fda-510(k)-data-analysis-2017.pdf. Date Accessed 15 Jan 2018
Eucomed Medical Technology (2013) Factsheet; Financial impact of the revision of the EU Medical Devices Directives on European SME’s and industry. www.medtecheurope.org/sites/default/files/resource_items/files/20130910_MTE_Financial%20impact%20of%20the%20Revision%20of%20the%20EU%20Medical%20Devices%20Directives%20on%20European%20SMEs%20and%20industry_factsheet.pdf. Date Accessed 28 Jan 2018
Eurostat (2017) Healthcare expenditure statistics; Statistics Explained. http://ec.europa.eu/eurostat/statisticsexplained/index.php/Healthcare_expenditure_statistics#Healthcare_expenditure. Date Accessed 01 Aug 2017
From Recall of DePuy Orthopaedics ASR Hip Replacement Device (2011) Therapeutic Goods Administration, used with permission of the Australian Government. https://www.tga.gov.au/behind-news/recall-depuy-orthopaedics-asr-hip-replacement-device. Date accessed 10 Nov 2017
From Regulation Impact Statement: Changes to premarket assessment requirements for medical devices (2013) Therapeutic Goods Administration, used with permission of the Australian Government https://www.tga.gov.au/sites/default/files/devices-reforms-premarket-scrutiny-ris-130626.pdf. Date accessed 01 Jan 2018
IMDRF (International Medical Device Regulators Forum) (2018a). http://www.imdrf.org/about/about.asp. Date Accessed 01 Aug 2018. Information based on material contained in the IMDRF website – About Us
IMDRF (International Medical Device Regulators Forum) (2018b). http://www.imdrf.org/ghtf/ghtf-archives.asp. Date Accessed 01 Aug 2018. Information based on material contained in the IMDRF website – GHTF Archives
IOM (Institute of Medicine) (2001) (US) Roundtable on research and development of drugs, biologics, and medical devices (ed: Hanna KE, Manning FJ, Bouxsein P, Pope A). The National Academies Press, Washington, DC
IOM (Institute of Medicine) 2010 (US) Public health effectiveness of the FDA 510(k) clearance process: balancing patient safety and innovation: workshop report, The National Academies Press, Washington, DC
Johnson & Johnson (2006) J&J presentation at 26th annual Cowen healthcare conference, March 7, 2006
Makower J, Meer A and Denend L (2010) FDA impact on US Medical Technology Innovation; A survey of over 200 medical technology companies. Stanford University, Stanford
Markets and Markets (2017) Spinal implants and surgical devices market. https://www.marketsandmarkets.com/PressReleases/spine-surgery-devices.asp. Date Accessed 10 Jan 2018
National Center for Health Statistics (2017) Health, United States, 2016 with Chartbook on long-term trends in health. National Center for Health Statistics, Hyattsville
National Center for Health Statistics (2018) Health, United States, 2017; With special feature on mortality. Hyattsville, MD
OECD (2015) Health at a glance 2015: OECD indicators. OECD Publishing, Paris. https://doi.org/10.1787/health_glance-2015-en
OECD (The Organisation for Economic Co-operation Development) (2018). http://www.oecd.org/about/membersandpartners. Date accessed 01 Aug 2018. Information based on material contained within the OECD website
Productivity Commission 2005, Economic implications of an ageing Australia, Research report, Canberra. Copyright Commonwealth of Australia, Productivity Commission reproduced by permission
Reed SD, Shea AM, Schulman KA (2008) Economic implications of potential changes to regulatory and reimbursement policies for medical devices. J Gen Intern Med 23(Suppl 1):50–56. https://doi.org/10.1007/s11606-007-0246-9
Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) Scientific opinion on the safety of Poly Implant Prothèse (PIP) silicone breast implants (2013 update) 25 September 2013
Sorenson C, Drummond M (2014) Improving medical device regulation: the United States and Europe in perspective. Milbank Q 92:114–150. https://doi.org/10.1111/1468-0009.12043
Sparks S, Freeman R and Davidson N (2011) Reimbursement and coverage strategies matter, here’s why. https://www.mddionline.com/reimbursement-and-coverage-strategies-matter-here’s-why, December 8, 2011. Date accessed 15 Jan 2018
Stirling C, Shehata A (2016) Collaboration – the future of innovation for the medical device industry. KPMG International Cooperative. https://assets.kpmg/content/dam/kpmg/pdf/2016/05/the-future-of-innovation-for-the-medical.pdf. Date accessed 01 Jan 2018
US Center for Disease Control and Prevention (2017) National Center For Health Statistics. Health. United States. With special feature on mortality. Hyattsville, MD. 2018
Walker BF, Muller R, Grant WD (2003) Low back pain in Australian adults; the economic burden. Asia Pac J Public Health 15(2):79–87
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Young, E. (2019). Effects of Reimbursement and Regulation on the Delivery of Spinal Device Innovation and Technology: An Industry Perspective. In: Cheng, B. (eds) Handbook of Spine Technology. Springer, Cham. https://doi.org/10.1007/978-3-319-33037-2_95-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-33037-2_95-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33037-2
Online ISBN: 978-3-319-33037-2
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences